Discontinued — last reported Q3 '25
Xylem Intangibles (Net) decreased by 2.6% to $2.21B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 5.1%, from $2.33B to $2.21B. Over 5 years (FY 2020 to FY 2025), Intangibles (Net) shows an upward trend with a 15.8% CAGR.
An increase often follows strategic acquisitions or significant R&D capitalization, while a decrease may indicate amortization or impairment charges.
This represents the net book value of non-physical assets, such as patents, trademarks, software, and customer relations...
Highly relevant for healthcare and technology firms; peers often disclose the composition of these assets in financial footnotes.
intangible_assets_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.06B | $1.04B | $1.02B | $1.00B | $975.00M | $933.00M | $930.00M | $915.00M | $3.19B | $3.04B | $2.53B | $2.45B | $2.37B | $2.33B | $2.38B | $2.33B | $2.35B | $2.32B | $2.27B | $2.21B |
| QoQ Change | — | -2.0% | -2.0% | -1.4% | -2.7% | -4.3% | -0.3% | -1.6% | +248.4% | -4.7% | -16.8% | -3.0% | -3.3% | -2.0% | +2.3% | -2.0% | +0.9% | -1.5% | -2.0% | -2.6% |
| YoY Change | — | — | — | — | -7.8% | -10.0% | -8.5% | -8.7% | +227.0% | +225.7% | +171.9% | +168.2% | -25.5% | -23.5% | -5.9% | -5.0% | -0.8% | -0.3% | -4.5% | -5.1% |